Method to treat atopic dermatitis
A method to treat the skin condition atopic dermatitis is described in this invention. The method comprises topical application of a composition containing cannabinoids, specifically cannabidiol and cannabigerol at a concentration of 3%-20% by weight of the composition. The method may further comprise administering chewing gum containing cannabinoids such as cannabidiol. Cannabidiol and cannabigerol may be sourced naturally or synthetically.
1. A method to treat atopic dermatitis, comprising:
administering a topical composition containing cannabinoids onto skin areas of a subject in need thereof,
wherein the cannabinoids are cannabidiol and cannabigerol at a total weight percent of 3% to 20% of the composition.
2. The method of claim 1 , wherein the cannabigerol is present at a twice to three times the weight of cannabidiol.
3. The method of claim 1 , wherein the cannabinoids in the composition are in powder form prior to incorporation into the composition.
4. The method of claim 1 , wherein the cannabinoids in the composition are in crystalline form prior to incorporation into the composition.
5. The method of claim 1 , wherein the cannabinoids in the composition are microencapsulated.
6. The method of claim 1 , wherein the cannabinoids in the composition are nanoencapsulated with particle sizes of 20 to 40 nanometers.
7. The method of claim 1 , wherein the composition further comprises a hyaluronic acid derivative.
8. The method of claim 7 , wherein the hyaluronic acid derivative is sodium oleyl hyaluronate.
9. The method of claim 8 , wherein the composition further comprises at least one of omega-3 or omega-6 fatty acids.
10. The method of claim 9 , wherein the composition further comprises cacao butter.
11. The method of claim 1 , wherein the composition is in a hydro gel form, a liquid form, a spray form, or a powder form.
12. The method of claim 1 , wherein the topical composition is applied twice a day for six weeks.
13. The method of claim 1 , further comprising oral administration of chewing gums containing at least one cannabinoid to the subject.
14. The method of claim 13 , wherein the at least one cannabinoid in the chewing gums is cannabidiol and the chewing gums contains 10 milligrams of cannabidiol in each piece.
15. The method of claim 13 , wherein the chewing gums contain 0.01% to 10% of cannabinoids by total weight of the chewing gum composition.
16. The method of claim 13 , wherein the chewing gums are administered 3 times per day for six weeks.